Publikationen in Zusammenarbeit mit Forschern von Erasmus University Medical Center (7)

2021

  1. Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

    European Journal of Cancer, Vol. 151, pp. 211-220

2019

  1. Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report

    Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2109-2119

2012

  1. Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure

    Clinical Cancer Research, Vol. 18, Núm. 11, pp. 3170-3179

  2. Randomized phase III study comparing paclitaxel/cisplatin/ gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987

    Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1107-1113

2008

  1. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

    European Urology, Vol. 53, Núm. 3, pp. 497-513

  2. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    European Urology, Vol. 53, Núm. 3, pp. 478-496

2004

  1. Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors

    Investigational New Drugs, Vol. 22, Núm. 3, pp. 329-333